Abstract
Background: Sexual dysfunction includingerectile dysfunction (ED) is common in patientswith end stage renal disease on peritonealdialysis (PD). Prevalence and determinants ofED in these patients has not been wellcharacterized.Patients and methods: Prevalence of ED in44 patients on chronic PD was assessed usingthe International Index of Erectile Function(IIEF-5) commonly called Sexual HealthInventory for Men (SHIM) score. Theassociations between ED and other medicalconditions was also assessed. Results: Prevalence of ED was high at88%. Mean age of all patients was 61.8± 13.9 years. Thirty-two patients werehypertensive, 19 of them had coronary arterydisease and 13 patients were diabetics. Allpatients with diabetes had ED. Age and diabeteswere found to be significantly associated withED.Conclusion: ED is highly prevalent inpatients on chronic PD. Increasing age anddiabetes were associated with higher percentageof ED.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Feldman HA, Goldstein I, Hatzichristou DG et al. Impotence and its medical and psychological correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.
Benet AE, Melman A. The epidemiology of erectile dysfunction. Urol Clin North Am 1995; 22(4): 699–709.
Population by sex and age. Statistics Canada, 1997.
Rosas SE, Joffe M, Franklin E, Strom BL et al. Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int 2001; 59: 2259–2266.
Rosen RC, Cappellen JC, Smith MD et al. Development and evaluation of an abridged, 5-item version of International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319–326.
Rosen RC, Riley A, Wagner G et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822–830.
Gudex CM. Health-related quality of life in end stage renal failure. Qual Life Res 1995; 4: 359–366.
Steele TE, Wuerth D, Finkelstein S et al. Sexual experience of the CAPD patient. J Am Soc Nephrol 1996: 7; 1165–1168.
Turks S, Karalezli G, Tonbul HZ et al. Erectile dysfunction and the effects of sildenafil in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2001; 16: 1818–1822.
Goldstein I, Luet TF, Padmanathan H, Rosen RC et al. Oral sildenafil in the treatment of erectile dysfunction. N Eng JMed 1998; 338: 1397–404.
Seibel I, Figuiredo C, Teleken C et al. Efficacy of oral sildenafil in haemodialysis patients with erectile dysfunction. J Am Soc Nephrol 2002; 13: 2770–2775.
Yenicerioglu Y, Kefi A, Aslan G et al. Efficacy and safety of sildenafil for treating erectile dysfunction in patients on dialysis. BJU International 2002; 90(40): 442–445.
Bellinghieri G, Santoro D, Forti L, Mallamace A et al. Am J Kidney Dis 2001; 38(4): S115–S117.
Macdougall IC, Mahon A, Muir G, Sidhu P. Randomised placebo-controlled study of sildefanil in peritoneal dialysis patients with erectile dysfunction. J Am Soc Nephrol 1999; 10: 318A.
Juergensen PH, Botev R, Wuerth D, Finkelstein SH et al. Erectile dysfunction in chronic peritoneal dialysis patients: incidence and treatment with sildenafil. Perit Dial Int 2001; 21: 355–359.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Krishnan, R., Izatt, S., Bargman, J.M. et al. Prevalence and determinants of erectile dysfunction in patients on peritoneal dialysis. Int Urol Nephrol 35, 553–556 (2003). https://doi.org/10.1023/B:UROL.0000025649.54702.a6
Issue Date:
DOI: https://doi.org/10.1023/B:UROL.0000025649.54702.a6